Glooko, a diabetes management startup, has pulled in $16.5 million from new investors, including medical device company Medtronic and Cannan Partners. Glooko sells a diabetes management healthcare service, which imports blood glucose readings from a variety of glucose meters via Bluetooth to make monitoring patients significantly easier for doctors. Glooko plans to integrate with CGMs (continuous glucose monitors) and insulin pumps to continue to create a unified approach to diabetes management and care. Glooko’s mission is to “improve diabetes outcomes at lower cost.” Their technology focuses on preventative care by offering a populations tracker which combines patient data with analytics. It also includes a module for predicting hypoglycemia unawareness with the hopes patients avoiding the risk and expense of hypo-related hospitalizations.
Read the full article here.
